Urinary plasminogen activator

From WikiMD's Food, Medicine & Wellness Encyclopedia

Urinary Plasminogen Activator (uPA) is a serine protease involved in the degradation of the extracellular matrix and in the process of cell migration and tissue remodeling. It plays a critical role in blood clot dissolution and is implicated in various physiological and pathological processes, including wound healing, angiogenesis, and the spread of cancer cells.

Function[edit | edit source]

uPA converts plasminogen, an inactive zymogen, into plasmin, an active enzyme that degrades many blood plasma proteins, most notably, fibrin clots. The activity of uPA is regulated by specific inhibitors, namely plasminogen activator inhibitor-1 (PAI-1) and plasminogen activator inhibitor-2 (PAI-2), which are important in maintaining the balance between hemostasis and fibrinolysis.

Clinical Significance[edit | edit source]

The expression of uPA and its receptor uPAR has been found to be elevated in several types of cancer, including breast, ovarian, and lung cancers. This overexpression is associated with increased invasion and metastasis, making uPA a potential target for cancer therapy. Additionally, uPA plays a role in atherosclerosis and myocardial infarction, as it is involved in the remodeling of blood vessels and the dissolution of thrombi.

Therapeutic Applications[edit | edit source]

Given its role in fibrinolysis, uPA has been explored as a therapeutic agent in the treatment of acute myocardial infarction and pulmonary embolism. However, its use is limited by the risk of bleeding and the development of specific inhibitors that can more safely modulate its activity.

Research and Development[edit | edit source]

Research into uPA has focused on developing specific inhibitors to block its activity in cancer progression and on finding ways to enhance its fibrinolytic activity for therapeutic use in cardiovascular diseases. Additionally, the uPA/uPAR system is being investigated as a potential diagnostic marker for cancer and as a target for novel anticancer therapies.


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD